The new antibiotic is at least 25,000 times more
potent against microbes such as VRE and VRSA, they report this week in the Proceedings of the National Academy of Sciences.
Drs. Baughn and Minato hope that the understanding of mechanisms for synergy will lead them and others to more
potent drug combinations that can be deployed in the fight
against pathogenic
microbes as drug resistance becomes increasingly commonplace.